SI1565451T1 - Derivati halotienoil-ciklopropan-1-karboksilne kisline - Google Patents
Derivati halotienoil-ciklopropan-1-karboksilne kislineInfo
- Publication number
- SI1565451T1 SI1565451T1 SI200330828T SI200330828T SI1565451T1 SI 1565451 T1 SI1565451 T1 SI 1565451T1 SI 200330828 T SI200330828 T SI 200330828T SI 200330828 T SI200330828 T SI 200330828T SI 1565451 T1 SI1565451 T1 SI 1565451T1
- Authority
- SI
- Slovenia
- Prior art keywords
- branched
- linear
- alkyl
- halothienoyl
- cyclopropane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02026597A EP1424333A1 (en) | 2002-11-28 | 2002-11-28 | Halothenoyl-cyclopropane-1-carboxylic acid derivatives |
| EP03811772A EP1565451B1 (en) | 2002-11-28 | 2003-11-25 | Halothienoyl-cyclopropane-1-carboxylic acid derivatives |
| PCT/EP2003/013244 WO2004048361A1 (en) | 2002-11-28 | 2003-11-25 | Halothenoyl-cyclopropane-1-carboxylic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1565451T1 true SI1565451T1 (sl) | 2007-08-31 |
Family
ID=32241303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200330828T SI1565451T1 (sl) | 2002-11-28 | 2003-11-25 | Derivati halotienoil-ciklopropan-1-karboksilne kisline |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060116329A1 (sl) |
| EP (2) | EP1424333A1 (sl) |
| JP (1) | JP4522864B2 (sl) |
| AT (1) | ATE361921T1 (sl) |
| AU (1) | AU2003296596B2 (sl) |
| CA (1) | CA2507597A1 (sl) |
| CY (1) | CY1106692T1 (sl) |
| DE (1) | DE60313798T2 (sl) |
| DK (1) | DK1565451T3 (sl) |
| ES (1) | ES2286509T3 (sl) |
| PT (1) | PT1565451E (sl) |
| SI (1) | SI1565451T1 (sl) |
| WO (1) | WO2004048361A1 (sl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1475088A1 (en) * | 2003-05-05 | 2004-11-10 | Newron Pharmaceuticals S.p.A. | Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract |
| GB2402940A (en) * | 2004-08-19 | 2004-12-22 | Pfizer Ltd | Biomarkers of inflammation and/or macrophage activation |
| US7592467B2 (en) * | 2005-04-11 | 2009-09-22 | Probiodrug Ag | Inhibitors of prolyl endopeptidase |
| AR086992A1 (es) | 2011-06-20 | 2014-02-05 | Bayer Ip Gmbh | Tienilpiri(mi)dinilpirazoles |
| EA201491606A1 (ru) | 2012-04-05 | 2015-03-31 | Схди Фаундейшн, Инк. | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения |
| US9938252B2 (en) | 2013-09-26 | 2018-04-10 | Chdi Foundation, Inc. | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| US9884853B2 (en) | 2013-09-26 | 2018-02-06 | Chdi Foundation, Inc. | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| GB201322512D0 (en) | 2013-12-19 | 2014-02-05 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| GB201508864D0 (en) | 2015-05-22 | 2015-07-01 | Glaxosmithkline Ip Dev Ltd | Compounds |
| GB201508857D0 (en) | 2015-05-22 | 2015-07-01 | Glaxosmithkline Ip Dev Ltd | Compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1278435B (de) * | 1965-01-19 | 1968-09-26 | Merck Ag E | Verfahren zur Herstellung von 1, 2-disubstituierten Cyclopropanderivaten |
| US4022903A (en) * | 1975-06-05 | 1977-05-10 | Abbott Laboratories | α-Thienyl and α-substituted thienyl, phenyl and substituted phenyl cyclopropylomethanols useful as biodegradable insecticides and mollusicides |
| US6274590B1 (en) * | 1993-01-15 | 2001-08-14 | G. D. Searle & Co. | Method of treating skin related conditions |
| WO1998018760A1 (fr) * | 1996-10-30 | 1998-05-07 | Shionogi & Co., Ltd. | Inhibiteur de la liberation du glutamate et nouveaux composes |
| GB9705031D0 (en) * | 1997-03-11 | 1997-04-30 | Pharmacia & Upjohn Spa | 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives |
-
2002
- 2002-11-28 EP EP02026597A patent/EP1424333A1/en not_active Withdrawn
-
2003
- 2003-11-25 PT PT03811772T patent/PT1565451E/pt unknown
- 2003-11-25 JP JP2004554463A patent/JP4522864B2/ja not_active Expired - Fee Related
- 2003-11-25 WO PCT/EP2003/013244 patent/WO2004048361A1/en active IP Right Grant
- 2003-11-25 DK DK03811772T patent/DK1565451T3/da active
- 2003-11-25 ES ES03811772T patent/ES2286509T3/es not_active Expired - Lifetime
- 2003-11-25 AU AU2003296596A patent/AU2003296596B2/en not_active Ceased
- 2003-11-25 US US10/536,307 patent/US20060116329A1/en not_active Abandoned
- 2003-11-25 DE DE60313798T patent/DE60313798T2/de not_active Expired - Lifetime
- 2003-11-25 AT AT03811772T patent/ATE361921T1/de not_active IP Right Cessation
- 2003-11-25 EP EP03811772A patent/EP1565451B1/en not_active Expired - Lifetime
- 2003-11-25 CA CA002507597A patent/CA2507597A1/en not_active Abandoned
- 2003-11-25 SI SI200330828T patent/SI1565451T1/sl unknown
-
2007
- 2007-07-02 CY CY20071100873T patent/CY1106692T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1565451A1 (en) | 2005-08-24 |
| JP4522864B2 (ja) | 2010-08-11 |
| AU2003296596A1 (en) | 2004-06-18 |
| JP2006509753A (ja) | 2006-03-23 |
| CY1106692T1 (el) | 2012-05-23 |
| DE60313798D1 (en) | 2007-06-21 |
| US20060116329A1 (en) | 2006-06-01 |
| WO2004048361A1 (en) | 2004-06-10 |
| ES2286509T3 (es) | 2007-12-01 |
| DE60313798T2 (de) | 2008-01-24 |
| CA2507597A1 (en) | 2004-06-10 |
| PT1565451E (pt) | 2007-08-03 |
| DK1565451T3 (da) | 2007-09-10 |
| AU2003296596B2 (en) | 2010-03-04 |
| ATE361921T1 (de) | 2007-06-15 |
| EP1424333A1 (en) | 2004-06-02 |
| EP1565451B1 (en) | 2007-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106692T1 (el) | Παραγωγα του αλοξενοϋλ-κυκλοπροπαν-1-καρβοξυλικου οξεος | |
| HN1997000027A (es) | Derivados de 6-fenil piridil - 2 amina | |
| DK1076663T3 (da) | Funktionaliserede alkyl- og alkenylsidekædederivater af glycinamider som farnesyltransferaseinhibitorer | |
| ES2193990T3 (es) | Derivados de purina. | |
| TW200612920A (en) | Novel imidazolidine derivatives | |
| EP1490371A4 (en) | TRICYCLIC COMPOUNDS BASED ON THIOPENE AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUNDS | |
| NO20044063L (no) | Pyranoner anvendelige som ATM-inhibitorer | |
| FI20001593A0 (fi) | Comt-entsyymiä inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia | |
| DK0947504T3 (da) | 16-en-vitamin D-derivater | |
| DE60223904D1 (de) | Benzylaminanalogen | |
| DK0753511T3 (da) | 4-indol-1-ylsmørsyrederivater, deres fremstilling og deres anvendelse som inhibitorer af alfa 1-adrenerge receptorer og testosteron-5alfa-reduktaser | |
| ATE201402T1 (de) | Optisch aktive thiazolidinonderivate | |
| HUP0303760A2 (hu) | AZ NF-kB faktort gátló szubsztituált benzoesavszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
| ES2190781T3 (es) | Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil-aminometilcromano. | |
| ATE199717T1 (de) | Benzothiophenverbindungen, ihre anwendungen und zusammensetzungen | |
| DK0912573T3 (da) | Camptothecinderivater, som er isoleret fra Mappia foetida, og anvendelse deraf som syntoner for nye lægemidler og som terapeutiske midler | |
| EA200200682A1 (ru) | Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие | |
| CA2419463A1 (en) | Primary intermediates for oxidative coloration of hair | |
| EP1112998A4 (en) | AMINE DERIVATIVES | |
| HK1035712A1 (en) | Benflumetol derivatives and their use against parasitical protozoa and trematodes. | |
| MX2023009666A (es) | Composicion herbicida. | |
| MY142362A (en) | Pharmaceutical composition for promoting angiogenesis | |
| MX2007010665A (es) | Nuevos derivados de aminoacidos fosfinicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| GB2437230A (en) | Miticidal triazolidine derivatives |